期刊文献+

慢性肾衰竭钙磷代谢紊乱的诊断及中西医结合治疗 被引量:16

Diagnosis of calcium and phosphorus metabolism disorder in chronic renal failure and treatment with integrative traditional Chinese and western medicine
原文传递
导出
摘要 钙磷代谢紊乱及其骨病是慢性肾衰竭特别是透析患者的重要并发症之一。长期骨矿物质代谢异常会引起全身血管钙化,与心血管事件的发生及死亡密切相关。2009年改善全球肾脏病预后组织(KDIGO)发布了慢性肾脏病矿物质及骨代谢紊乱(CKD-MBD)的诊断、评估、预防和治疗的临床实践指南,2013年KDIGO新发布的《CKD评估与管理临床实践指南》又针对CKD骨代谢疾病提出了新的观点。治疗的重点是降低高血磷和维持血钙,控制甲状旁腺激素在目标范围。中医治疗慢性肾衰竭钙磷代谢紊乱有独到之处,通过辩证施治,同时结合必要的西药治疗,可显著改善患者的临床生化指标及自觉症状,改善预后。 Calcium and phosphorus metabolism disorder and bone disease are important complications in patients with chronic renal failure especially undergoing dialysis. Long-term metabolism disorder of bone mineral content can cause systemic vascular calcification, which is closely associated with cardiovascular events and mortality. In :2009, Kidney Disease: Improving Global Outcomes (KDIGO) published the mineral and bone disorder of chronic kidney disease (CKD) guidelines. In 2013, KDIGO proposed some new perspectives about CKD metabolic bone diseases in "Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease". The treatment for these complications mainly aims to decrease the high blood phosphate, maintain the level of blood calcium, and keep parathyroid hormone (PTH) within defined levels. It is unique for traditional Chinese medicine to treat the calcium and phosphorus metabolism disorder through dialectical therapy and integration with western medicine necessary, which can significantly improve the clinical symptoms, biochemical indices, and the prognosis.
作者 李伟 周乐
出处 《中华肾病研究电子杂志》 2013年第5期27-31,共5页 Chinese Journal of Kidney Disease Investigation(Electronic Edition)
关键词 慢性肾衰竭 钙磷代谢 中西医结合 治疗 Chronic renal failure Calcium and phosphorus metabolism Integrative traditional Chinese and western medicine Treatment
  • 相关文献

参考文献27

  • 1陈香美,王海燕.提高慢性肾脏病的知晓率、治疗率和控制率减轻对国民健康的危害[J].中华内科杂志,2006,45(6):441-442. 被引量:65
  • 2Moranne O,Froissart M,Rossert J. Timing of onset of CKD-Related metabolic complications[J].{H}Journal of the American Society of Nephrology,2009,(01):164-171.
  • 3Covic A,Kothawala P,Bernal M. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality,cardiovascular mortality and cardiovascular events in chronic kidney disease[J].{H}Nephrology Dialysis Transplantation,2009,(05):1506-1523.
  • 4Kidney Disease Improving Global Outcomes (KDIGO)CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis,evaluation,prevention,and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)[J].{H}Kidney International,2009,(Suppl 113):S1-130.
  • 5Kidney Disease Improving Global Outcomes (KDIGO)CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease[J].{H}Kidney International,2013,(Suppl 1):1-150.
  • 6Regidor DL,Kovesdy CP,Mehrotra R. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients[J].{H}Journal of the American Society of Nephrology,2008,(11):2193-2203.
  • 7Barreto FC,Barreto DV,Moyses RM. K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients[J].{H}Kidney International,2008,(06):771-777.
  • 8Teresa A,Joao MF. Cardiovascular risk in dialysis patients:X-ray vision on vascular calfications[J].{H}Kidney International,2008,(12):1505-1507.
  • 9Benini O,D′Alessandro C,Gianfaldoni D. Extra-phosphate load from food additives in commonly eaten foods:a real and insidious danger for renal patients[J].{H}Journal of Renal Nutrition,2011,(04):303-308.
  • 10Cupisti A,D′Alessandro C. The impact of known and unknown dietary components to phosphorus intake[J].G Ital Nefrol,2011,(03):278-288.

二级参考文献47

共引文献116

同被引文献232

引证文献16

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部